Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2024.0885 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Harrison Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Drug Hypersensitivity Syndrome, Herpesvirus 6, Human, Roseolovirus Infections, Virus Activation. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, Baylor College of Medicine, Houston, Texas.
- Division of General Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Dermatology, Baylor College of Medicine, Houston, Texas.
Zitieren
APA
Zhu, H., Komaroff, A. L., & Ren, V. (2024). Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.0885
Vancouver
Zhu H, Komaroff AL, Ren V. Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.0885
BibTeX
@article{Zhu2024,
author = {Zhu, Harrison and Komaroff, Anthony L and Ren, Vicky},
title = {Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2024.0885}
}
EUVIMED